Development of an Immunoassay for Quantification of Soluble Human CD40L (CD154) in Plasma Samples

被引：0
|
作者：
Pedersen, Kathrine [1 ]
Laursen, Nick Stub [2 ]
Hansen, Annette Gudmann [1 ]
Palarasah, Yaseelan [3 ]
Thiel, Steffen [1 ]
机构：
[1] Aarhus Univ, Dept Biomed, Aarhus, Denmark
[2] Commit Biol ApS, Aarhus, Denmark
[3] Univ Southern Denmark, Dept Mol Med, Odense, Denmark
来源：
EUROPEAN JOURNAL OF IMMUNOLOGY | 2024年 / 54卷
关键词：
D O I：
暂无
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
1129 - P2.
引用
收藏
页码：1176 / 1176
页数：1
相关论文
共 50 条
  • [31] Transforming growth factor β enhances the expression of CD154 (CD40L) and production of tumor necrosis factor α by human T lymphocytes
    Gray, JD
    Liu, TF
    Huynh, N
    Horwitz, DA
    IMMUNOLOGY LETTERS, 2001, 78 (02) : 83 - 88
  • [32] A polymorphic CD40 Ligand (CD154) molecule mediates CD40-dependent signalling but interferes with the ability of soluble CD40 to functionally block CD154:CD40 interactions
    Barnhart, B
    Ford, GS
    Bhushan, A
    Song, C
    Covey, LR
    IMMUNOLOGY, 2000, 99 (01) : 54 - 61
  • [33] Inhibition of CD40–CD154 costimulatory pathway by a cyclic peptide targeting CD154
    Ilaria Deambrosis
    Sara Lamorte
    Fulvia Giaretta
    Lorenzo Tei
    Luigi Biancone
    Benedetta Bussolati
    Giovanni Camussi
    Journal of Molecular Medicine, 2009, 87 : 181 - 197
  • [34] CD40L (CD154) fusion protein with pulmonary surfactant protein D as a prototype for soluble multimeric TNF superfamily ligand molecules.
    Kornbluth, RS
    Kee, K
    Truong, NH
    FASEB JOURNAL, 2000, 14 (06): : A1162 - A1162
  • [35] Increased expression of CD154 (CD40L) on stimulated T-cells from patients with psoriatic arthritis
    Daoussis, D.
    Antonopoulos, I.
    Andonopoulos, A. P.
    Liossis, S. -N. C.
    RHEUMATOLOGY, 2007, 46 (02) : 227 - 231
  • [36] Elevated soluble CD40-ligand (CD154) in plasma of patients with systemic lupus erythematosus.
    Kato, K
    Santana-Sahagún, E
    Rassenti, LZ
    Weisman, MH
    Kipps, TJ
    ARTHRITIS AND RHEUMATISM, 1998, 41 (09): : S71 - S71
  • [37] Inhibition of a secondary human alloimmune response via the soluble active component of CD154 (CD40L) in severe combined immune-deficient mice engrafted with human lymphocytes
    Lazarus, AH
    Crow, AR
    Freedman, J
    Blanchette, V
    Hannach, B
    TRANSFUSION, 1999, 39 (08) : 818 - 823
  • [38] Elevated levels of soluble CD40 ligand (CD154) in pelvic fluid and plasma is found in endometriosis
    Reddy, S
    Reddy, Y
    Phipps, RP
    FASEB JOURNAL, 2004, 18 (04): : A444 - A444
  • [39] The Role of Soluble CD40L Ligand in Human Carcinogenesis
    Angelou, Anastasios
    Antoniou, Efstathios
    Garmpis, Nikolaos
    Damaskos, Christos
    Theocharis, Stamatios
    Margonis, Georgios-Antonios
    ANTICANCER RESEARCH, 2018, 38 (05) : 3199 - 3201
  • [40] Soluble CD154 initiates rejection
    Karen Honey
    Nature Reviews Immunology, 2006, 6 : 256 - 256
12345